CS161757B2 - - Google Patents

Info

Publication number
CS161757B2
CS161757B2 CS4621A CS462170A CS161757B2 CS 161757 B2 CS161757 B2 CS 161757B2 CS 4621 A CS4621 A CS 4621A CS 462170 A CS462170 A CS 462170A CS 161757 B2 CS161757 B2 CS 161757B2
Authority
CS
Czechoslovakia
Application number
CS4621A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS161757B2 publication Critical patent/CS161757B2/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
CS4621A 1969-07-24 1970-07-02 CS161757B2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1938218A DE1938218C3 (de) 1969-07-24 1969-07-24 9 a,21,21-Trichlor-ll ß-fluor- pregnene, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CS161757B2 true CS161757B2 (fr) 1975-06-10

Family

ID=5741103

Family Applications (1)

Application Number Title Priority Date Filing Date
CS4621A CS161757B2 (fr) 1969-07-24 1970-07-02

Country Status (18)

Country Link
US (1) US3681405A (fr)
JP (1) JPS4815290B1 (fr)
AT (1) AT300217B (fr)
BE (1) BE753874A (fr)
CH (1) CH557339A (fr)
CS (1) CS161757B2 (fr)
DE (1) DE1938218C3 (fr)
DK (1) DK122454B (fr)
ES (1) ES381790A1 (fr)
FI (1) FI46844C (fr)
FR (1) FR2059554B1 (fr)
GB (1) GB1317194A (fr)
IE (1) IE34401B1 (fr)
IL (1) IL34976A (fr)
NL (1) NL7010876A (fr)
PL (1) PL79781B1 (fr)
SE (1) SE355578B (fr)
ZA (1) ZA704574B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
JP5780521B2 (ja) 2008-05-28 2015-09-16 リベラジェン・バイオファーマ・インコーポレイテッドReveraGen BioPharma,Inc. 疾患を治療するための、NF−κBの非ホルモン性ステロイド調節因子
EP2556083A4 (fr) 2010-04-05 2013-12-04 Validus Biopharma Inc Modulateurs stéroïdes non hormonaux de nf- kappa b pour le traitement de maladies
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236866A (en) * 1959-04-08 1966-02-22 Syntex Corp 21, 21-difluoro pregnenes
US3025312A (en) * 1959-07-14 1962-03-13 Olin Mathieson 9alpha, 11beta-dichloro pregnanes
US3038898A (en) * 1960-11-10 1962-06-12 Syntex Sa 6-fluoromethyl-9alpha, 11beta-dichlorocortical hormones

Also Published As

Publication number Publication date
IE34401L (en) 1971-01-24
FI46844B (fr) 1973-04-02
PL79781B1 (fr) 1975-06-30
US3681405A (en) 1972-08-01
BE753874A (fr) 1971-01-25
DE1938218A1 (de) 1971-02-04
IL34976A (en) 1973-06-29
DE1938218C3 (de) 1978-10-19
ZA704574B (en) 1971-03-31
SE355578B (fr) 1973-04-30
CH557339A (de) 1974-12-31
DK122454B (da) 1972-03-06
ES381790A1 (es) 1972-12-01
FR2059554A1 (fr) 1971-06-04
JPS4815290B1 (fr) 1973-05-14
NL7010876A (fr) 1971-01-26
GB1317194A (en) 1973-05-16
DE1938218B2 (de) 1978-01-26
AT300217B (de) 1972-07-25
IL34976A0 (en) 1970-09-17
FI46844C (fi) 1973-07-10
FR2059554B1 (fr) 1974-06-14
IE34401B1 (en) 1975-04-30

Similar Documents

Publication Publication Date Title
AU2270770A (fr)
AU465452B2 (fr)
AU429630B2 (fr)
AU450150B2 (fr)
JPS4815290B1 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU427401B2 (fr)
AU442357B2 (fr)
AU425297B2 (fr)
AU417208B2 (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AU428131B2 (fr)
AU414607B2 (fr)
AU470661B1 (fr)
AU438128B2 (fr)
AU442554B2 (fr)
AU442285B2 (fr)
AU442322B2 (fr)
AU442538B2 (fr)
AU410358B2 (fr)
AU442535B2 (fr)
AU442380B2 (fr)